Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

VHH characterization.Recombinant VHHs: Production, characterization and affinity.

Chabrol E, Stojko J, Nicolas A, Botzanowski T, Fould B, Antoine M, Cianférani S, Ferry G, Boutin JA.

Anal Biochem. 2019 Oct 30;589:113491. doi: 10.1016/j.ab.2019.113491. [Epub ahead of print]

PMID:
31676284
2.

Glycine receptor autoantibodies disrupt inhibitory neurotransmission.

Crisp SJ, Dixon CL, Jacobson L, Chabrol E, Irani SR, Leite MI, Leschziner G, Slaght SJ, Vincent A, Kullmann DM.

Brain. 2019 Nov 1;142(11):3398-3410. doi: 10.1093/brain/awz297.

3.

VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.

Hartmann L, Botzanowski T, Galibert M, Jullian M, Chabrol E, Zeder-Lutz G, Kugler V, Stojko J, Strub JM, Ferry G, Frankiewicz L, Puget K, Wagner R, Cianférani S, Boutin JA.

Protein Sci. 2019 Oct;28(10):1865-1879. doi: 10.1002/pro.3712. Epub 2019 Aug 29.

PMID:
31423659
4.

Epilepsy Gene Therapy Using an Engineered Potassium Channel.

Snowball A, Chabrol E, Wykes RC, Shekh-Ahmad T, Cornford JH, Lieb A, Hughes MP, Massaro G, Rahim AA, Hashemi KS, Kullmann DM, Walker MC, Schorge S.

J Neurosci. 2019 Apr 17;39(16):3159-3169. doi: 10.1523/JNEUROSCI.1143-18.2019. Epub 2019 Feb 12.

5.

Semiology, clustering, periodicity and natural history of seizures in an experimental occipital cortical epilepsy model.

Chang BL, Leite M, Snowball A, Lieb A, Chabrol E, Walker MC, Kullmann DM, Schorge S, Wykes RC.

Dis Model Mech. 2018 Dec 14;11(12). pii: dmm036194. doi: 10.1242/dmm.036194.

6.

Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.

Porkolab V, Chabrol E, Varga N, Ordanini S, Sutkevičiu Tė I, Thépaut M, García-Jiménez MJ, Girard E, Nieto PM, Bernardi A, Fieschi F.

ACS Chem Biol. 2018 Mar 16;13(3):600-608. doi: 10.1021/acschembio.7b00958. Epub 2018 Jan 8.

7.

Langerin-heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments.

Muñoz-García JC, Chabrol E, Vivès RR, Thomas A, de Paz JL, Rojo J, Imberty A, Fieschi F, Nieto PM, Angulo J.

J Am Chem Soc. 2015 Apr 1;137(12):4100-10. doi: 10.1021/ja511529x. Epub 2015 Mar 23.

PMID:
25747117
8.

Alteration of the langerin oligomerization state affects Birbeck granule formation.

Chabrol E, Thépaut M, Dezutter-Dambuyant C, Vivès C, Marcoux J, Kahn R, Valladeau-Guilemond J, Vachette P, Durand D, Fieschi F.

Biophys J. 2015 Feb 3;108(3):666-77. doi: 10.1016/j.bpj.2014.10.075.

9.

Naturally processed non-canonical HLA-A*02:01 presented peptides.

Hassan C, Chabrol E, Jahn L, Kester MG, de Ru AH, Drijfhout JW, Rossjohn J, Falkenburg JH, Heemskerk MH, Gras S, van Veelen PA.

J Biol Chem. 2015 Jan 30;290(5):2593-603. doi: 10.1074/jbc.M114.607028. Epub 2014 Dec 12.

10.

The molecular bases of δ/αβ T cell-mediated antigen recognition.

Pellicci DG, Uldrich AP, Le Nours J, Ross F, Chabrol E, Eckle SB, de Boer R, Lim RT, McPherson K, Besra G, Howell AR, Moretta L, McCluskey J, Heemskerk MH, Gras S, Rossjohn J, Godfrey DI.

J Exp Med. 2014 Dec 15;211(13):2599-615. doi: 10.1084/jem.20141764. Epub 2014 Dec 1.

11.

Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.

Cottenie E, Kochanski A, Jordanova A, Bansagi B, Zimon M, Horga A, Jaunmuktane Z, Saveri P, Rasic VM, Baets J, Bartsakoulia M, Ploski R, Teterycz P, Nikolic M, Quinlivan R, Laura M, Sweeney MG, Taroni F, Lunn MP, Moroni I, Gonzalez M, Hanna MG, Bettencourt C, Chabrol E, Franke A, von Au K, Schilhabel M, Kabzińska D, Hausmanowa-Petrusewicz I, Brandner S, Lim SC, Song H, Choi BO, Horvath R, Chung KW, Zuchner S, Pareyson D, Harms M, Reilly MM, Houlden H.

Am J Hum Genet. 2014 Nov 6;95(5):590-601. doi: 10.1016/j.ajhg.2014.10.002. Epub 2014 Oct 30.

12.

Neural ECM and epilepsy.

Pitkänen A, Ndode-Ekane XE, Łukasiuk K, Wilczynski GM, Dityatev A, Walker MC, Chabrol E, Dedeurwaerdere S, Vazquez N, Powell EM.

Prog Brain Res. 2014;214:229-62. doi: 10.1016/B978-0-444-63486-3.00011-6. Review.

PMID:
25410361
13.

Seizure semiology in autosomal dominant epilepsy with auditory features, due to novel LGI1 mutations.

Sadleir LG, Agher D, Chabrol E, Elkouby L, Leguern E, Paterson SJ, Harty R, Bellows ST, Berkovic SF, Scheffer IE, Baulac S.

Epilepsy Res. 2013 Dec;107(3):311-7. doi: 10.1016/j.eplepsyres.2013.09.008. Epub 2013 Oct 8.

PMID:
24206907
14.

Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.

Thépaut M, Guzzi C, Sutkeviciute I, Sattin S, Ribeiro-Viana R, Varga N, Chabrol E, Rojo J, Bernardi A, Angulo J, Nieto PM, Fieschi F.

J Am Chem Soc. 2013 Feb 20;135(7):2518-29. doi: 10.1021/ja3053305. Epub 2013 Feb 8.

PMID:
23360500
15.

Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode.

Chabrol E, Nurisso A, Daina A, Vassal-Stermann E, Thepaut M, Girard E, Vivès RR, Fieschi F.

PLoS One. 2012;7(11):e50722. doi: 10.1371/journal.pone.0050722. Epub 2012 Nov 30.

16.

c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration.

Arthur-Farraj PJ, Latouche M, Wilton DK, Quintes S, Chabrol E, Banerjee A, Woodhoo A, Jenkins B, Rahman M, Turmaine M, Wicher GK, Mitter R, Greensmith L, Behrens A, Raivich G, Mirsky R, Jessen KR.

Neuron. 2012 Aug 23;75(4):633-47. doi: 10.1016/j.neuron.2012.06.021.

17.

A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.

Berzi A, Reina JJ, Ottria R, Sutkeviciute I, Antonazzo P, Sanchez-Navarro M, Chabrol E, Biasin M, Trabattoni D, Cetin I, Rojo J, Fieschi F, Bernardi A, Clerici M.

AIDS. 2012 Jan 14;26(2):127-37. doi: 10.1097/QAD.0b013e32834e1567.

18.

Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.

Andreini M, Doknic D, Sutkeviciute I, Reina JJ, Duan J, Chabrol E, Thepaut M, Moroni E, Doro F, Belvisi L, Weiser J, Rojo J, Fieschi F, Bernardi A.

Org Biomol Chem. 2011 Aug 21;9(16):5778-86. doi: 10.1039/c1ob05573a. Epub 2011 Jul 7.

19.

Screening of OPTN in French familial amyotrophic lateral sclerosis.

Millecamps S, Boillée S, Chabrol E, Camu W, Cazeneuve C, Salachas F, Pradat PF, Danel-Brunaud V, Vandenberghe N, Corcia P, Le Forestier N, Lacomblez L, Bruneteau G, Seilhean D, Brice A, Feingold J, Meininger V, LeGuern E.

Neurobiol Aging. 2011 Mar;32(3):557.e11-3. doi: 10.1016/j.neurobiolaging.2010.11.005. Epub 2011 Jan 8.

PMID:
21220178
20.

Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues.

Brun-Heath I, Ermonval M, Chabrol E, Xiao J, Palkovits M, Lyck R, Miller F, Couraud PO, Mornet E, Fonta C.

Cell Tissue Res. 2011 Mar;343(3):521-36. doi: 10.1007/s00441-010-1111-4. Epub 2010 Dec 31.

PMID:
21191615
21.

Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice.

Chabrol E, Navarro V, Provenzano G, Cohen I, Dinocourt C, Rivaud-Péchoux S, Fricker D, Baulac M, Miles R, Leguern E, Baulac S.

Brain. 2010 Sep;133(9):2749-62. doi: 10.1093/brain/awq171. Epub 2010 Jul 21.

22.

A novel three base-pair LGI1 deletion leading to loss of function in a family with autosomal dominant lateral temporal epilepsy and migraine-like episodes.

de Bellescize J, Boutry N, Chabrol E, André-Obadia N, Arzimanoglou A, Leguern E, Baulac S, Calender A, Ryvlin P, Lesca G.

Epilepsy Res. 2009 Jul;85(1):118-22. doi: 10.1016/j.eplepsyres.2009.02.007. Epub 2009 Mar 5.

PMID:
19268539
23.

A case of lethal hypophosphatasia providing new insights into the perinatal benign form of hypophosphatasia and expression of the ALPL gene.

Brun-Heath I, Chabrol E, Fox M, Drexler K, Petit C, Taillandier A, De Mazancourt P, Serre JL, Mornet E.

Clin Genet. 2008 Mar;73(3):245-50. Epub 2007 Oct 7.

PMID:
17922851
24.

Absence of mutations in the LGI1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy.

Chabrol E, Gourfinkel-An I, Scheffer IE, Picard F, Couarch P, Berkovic SF, McMahon JM, Bajaj N, Mota-Vieira L, Mota R, Trouillard O, Depienne C, Baulac M, LeGuern E, Baulac S.

Epilepsy Res. 2007 Aug;76(1):41-8. Epub 2007 Aug 6.

PMID:
17681454
25.

Two novel epilepsy-linked mutations leading to a loss of function of LGI1.

Chabrol E, Popescu C, Gourfinkel-An I, Trouillard O, Depienne C, Senechal K, Baulac M, LeGuern E, Baulac S.

Arch Neurol. 2007 Feb;64(2):217-22.

PMID:
17296837
26.

[Views of our elders on the moral and intellectual protection of the future physician].

Chabrol E.

Bull Acad Natl Med. 1968 Dec 10;152(32):573-5. French. No abstract available.

PMID:
4887389
27.

[Delusional interpretation of digestive radiology].

Chabrol E.

Bull Acad Natl Med. 1967 Apr 18;151(13):241-5. French. No abstract available.

PMID:
4877089
28.

[The preventive work of the Academie Nationale de Medecine in the hundred years since Pasteur].

CHABROL E.

Presse Med. 1960 Sep 3;68:1413-9. French. No abstract available.

PMID:
13692118
29.

[Cholesterol as seen by physicians in 1937].

CHABROL E.

Gaz Med Fr. 1959 Jul 25;66(14):1199-200 passim. French. No abstract available.

PMID:
13672366
30.

[Results of climatotherapy without drug adjuvants in scholastic preventorium].

CHABROL E.

Bull Acad Natl Med. 1958 Apr 15-22;142(13-14):375-82. French. No abstract available.

PMID:
13536608
31.

Raymond Charonnat; 1894-1957.

CHABROL E.

Presse Med. 1958 Feb 5;66(10):212. No abstract available.

PMID:
13542529
32.

A propos de la vaccination anti-grippale.

CHABROL E.

Bull Acad Natl Med. 1957 Oct 8-15;141(24-25):527-8. French. No abstract available.

PMID:
13500048
33.

A. Gilbert; 1858-1927.

CHABROL E.

Bull Acad Natl Med. 1956 Dec 11-18;140(34-35):632-42. French. No abstract available.

PMID:
13404346
34.

[Jaundice epidemics seen by the practiciens in 1850].

CHABROL E.

Bull Acad Natl Med. 1956 Feb 21-28;140(7-8):114-8. French. No abstract available.

PMID:
13356072
35.

[Present conception of severe types of jaundice and their treatment].

CHABROL E.

Rev Prat. 1955 Jul 11;5(20):2075-82. French. No abstract available.

PMID:
13246405
36.

[Development of social medicine in Venezuela].

CHABROL E.

Bull Acad Natl Med. 1955 Jun 21-28;139(21-22):350-2. French. No abstract available.

PMID:
13260754
37.

[Liver in arthritis].

CHABROL E.

Concours Med. 1955 Jan 8;77(2):149-50. French. No abstract available.

PMID:
13231475
38.

[Pseudo-lithiasic pains in peripancreatitis of lymph node origin].

CHABROL E, GIRAULD A.

Rev Int Hepatol. 1955;5(6):917-24. French. No abstract available.

PMID:
13311113
39.

[Mucomembranous colopathy].

CHABROL E.

Rev Prat. 1954 Jul 11;4(20):1817-21. Undetermined Language. No abstract available.

PMID:
13186592
40.

[Medicosurgical treatment of infectious jaundice].

CHABROL E.

Rev Prat. 1954 Apr 21;4(12):1117-21. Undetermined Language. No abstract available.

PMID:
13168028
41.

[Is xanthomatous liver cirrhosis related to virus hepatitis?].

CHABROL E.

Rev Prat. 1954 Apr 21;4(12):1089-94. Undetermined Language. No abstract available.

PMID:
13168025
42.

[Introduction to the study of cholelithiasis and biliary dyskinesia].

CHABROL E.

Rev Int Hepatol. 1954;4(2-3):199-206. French. No abstract available.

PMID:
14372604
43.

[Biliary mucin and albumin].

CHABROL E, BOSZERMANYI M, FALLOT P.

Rev Int Hepatol. 1954;4(1):185-91. French. No abstract available.

PMID:
14358017
44.

[Definition and classification of cirrhosis].

CHABROL E.

Vie Med. 1953 Dec;34(12):1063-7. Undetermined Language. No abstract available.

PMID:
13136871
45.

[Alcoholism and cirrhosis].

CHABROL E, GIRAULD A.

Bull Acad Natl Med. 1953 Jun 30;137(24):374-7. Undetermined Language. No abstract available.

PMID:
13082216
46.

[Introduction to the study of cholelithiasis].

CHABROL E.

Rev Prat. 1953 May 1;3(13):867-71. Undetermined Language. No abstract available.

PMID:
13075565
47.

[The lessons from a fistula caused by cholecystostomy dating back sixteen years].

CHABROL E.

Bull Acad Natl Med. 1953 Feb;137(7-8):128-33. Undetermined Language. No abstract available.

PMID:
13051633
48.

[The crisis of the long medical meetings].

CHABROL E.

Sem Medicale Med Soc. 1953 Jan 14;29(2):13-5. Undetermined Language. No abstract available.

PMID:
13089804
49.

[Thermo-climatic therapy of hepato-endocrine diseases in France].

CHABROL E.

Rev Int Hepatol. 1953;3(4):511-8. Undetermined Language. No abstract available.

PMID:
13135055
50.

[A. Gilbert].

CHABROL E.

Vie Med. 1952 Dec;33(Spec No):104. French. No abstract available.

PMID:
13029405

Supplemental Content

Loading ...
Support Center